Due to the inherent complexity of the CKM syndrome, its effective management requires a multifaceted approach targeting its pathophysiology and its interconnected pathways, such as inflammation, oxidative stress, insulin resistance, hyperglycemia, dyslipidemia, the renin–angiotensin–aldosterone system, and neurohormonal and vascular dysregulation [60]. This evidence concerns the gene REN and Insulin resistance.